ArticleScientific reports2025
Partially amorphous iron-copper-nickel sulfides for robust bifunctional electrocatalysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bifunctional electrocatalysts are in demand to pursue dual functions in applications like energy conversion and pollution treatment. In this study, we synthesize the iron-copper-nickel sulfide (FeCuNiS) catalysts with partial amorphous character via the hydrothermal method. The iron rich composition with optimal copper and nickel ratios exhibits robust performances on hydrogen evolution reaction (HER) and oxygen evolution reaction (OER) in alkaline conditions. The partial amorphous feature offers more active sites for reaction due to the partial disordered structure. The partially amorphous FeCuNiS exhibits lower overpotential for HER and OER at 50 mAcm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.